Physician profile
David I Bender
NPI 1013291103
$2,046.74
in general payments reported to CMS, 2019-2025
20 companies · $324 in 2025
The $324 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $213 · 2021: $304 · 2022: $208 · 2023: $327 · 2024: $373 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $385.02 | 2019-2025 | Bexsero |
| Merck Sharp & Dohme LLC | $222.14 | 2021-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Phadia US INC. | $208.33 | 2019-2024 | Immunocap |
| Cranial Technologies, INC | $186.53 | 2019-2025 | Doc Band |
| Pfizer INC. | $155.61 | 2019-2022 | |
| Sanofi Pasteur INC. | $140.12 | 2022-2025 | |
| Kaleo, INC. | $140.09 | 2019-2023 | Auvi-Q |
| Regeneron Healthcare Solutions, INC. | $123.24 | 2024 | Dupixent |
| Nobel Biocare USA | $113.80 | 2022 | |
| Alk-Abello, INC | $99.28 | 2023-2025 | Neffy, Grastek, Ragwitek |
| Sanofi-Aventis U.S. LLC | $64.44 | 2024-2025 | |
| Boston Scientific Corporation | $42.66 | 2023-2024 | Bodyguardian |
| Ars Pharmaceuticals Operations, INC. | $28.11 | 2025 | Neffy |
| Sobi, INC | $26.71 | 2023 | |
| Genzyme Corporation | $23.20 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $22.75 | 2024 | |
| Verrica Pharmaceuticals INC. | $21.19 | 2025 | Ycanth |
| Teva Pharmaceuticals USA, INC. | $16.45 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.08 | 2025 | Zoryve |
| Biofire Diagnostics, LLC | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.